SCHEMBL31034827

SCHEMBL31034827

CCC1(c2cn(C(=O)N3CCCCC3)cn2)Cc2ccccc2C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
TSHR P16473 1/20 0.38
HRH3 Q9Y5N1 1/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RYR2 Q92736 1/20 0.35
HCN1 O60741 1/20 0.35
HCN4 Q9Y3Q4 1/20 0.35
USP2 O75604 1/20 0.35
ADRA2A P08913 1/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
ADRA1B P35368 1/20 0.34
HSD11B1 P28845 1/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 1/20 0.34
NPSR1 Q6W5P4 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31034870 0.80 FAAH (0.39) TSHRHRH3POLBRYR2ADRA2A
SCHEMBL31034887 0.80 POLB (0.41) TSHRHRH3POLBSMN1; SMN2RYR2
SCHEMBL31034900 0.79 FAAH (0.43) HRH3POLBADRA2AADRA2BADRA2C
SCHEMBL31034854 0.76 ADRA2A (0.37) ADRA2AADRA2BADRA2CADRA1B
SCHEMBL31034838 0.74 FAAH (0.42) KMT2AHRH3SMN1; SMN2
SCHEMBL9325910 0.73 ADRA2A (0.43) MEN1KMT2ATSHRHRH3ALDH1A1
SCHEMBL9325735 0.72 ADRA2A (0.42) KMT2ATSHRALDH1A1ADRA2AADRA2B
SCHEMBL9324722 0.70 ADRA2A (0.40) MEN1KMT2AALDH1A1ADRA2AADRA2B
SCHEMBL31034923 0.68 POLB (0.38) TSHRPOLBSMN1; SMN2RYR2SLC6A2
SCHEMBL9325930 0.68 HPGDS (0.40) POLBADRA2AADRA2BADRA2CADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658639-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES Univerza V Ljubljani (SI) 2025-12-10 EP claimed
WO-2024160908-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERZA V LJUBLJANI (SI) 2024-08-08 WO claimed
EP-4658639-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES Univerza V Ljubljani (SI) 2025-12-10 EP disclosed
WO-2024160908-A1 N,N-DIALKYL-4-(2-ETHYLINDAN-2-YL)-1H-IMIDAZOLE-1-CARBOXAMIDES AND RELATED COMPOUNDS FOR TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERZA V LJUBLJANI (SI) 2024-08-08 WO disclosed